Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB.

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02

Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol (2012) 4.36

Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol (2012) 2.84

Amyloid-β associated cortical thinning in clinically normal elderly. Ann Neurol (2011) 2.57

β-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology (2012) 2.49

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology (2012) 2.26

Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol (2014) 2.13

Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models. Neuroimage (2012) 2.11

Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology (2012) 2.01

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol (2014) 1.96

Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J Neurosci (2012) 1.76

Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults. J Neurosci (2011) 1.74

Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals. J Alzheimers Dis (2010) 1.73

Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron (2013) 1.54

Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases. Neurology (2013) 1.53

Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci (2011) 1.51

Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia. Neurobiol Aging (2011) 1.51

Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging (2012) 1.43

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. Mol Psychiatry (2014) 1.42

Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology (2015) 1.40

Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment. BMC Neurol (2015) 1.38

CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex (2011) 1.38

Cerebrovascular disease, β-amyloid, and cognition in aging. Neurobiol Aging (2011) 1.37

The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron (2014) 1.35

Longitudinal patterns of β-amyloid deposition in nondemented older adults. Arch Neurol (2011) 1.32

Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum. Brain (2015) 1.31

Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2. Alzheimers Dement (2011) 1.29

Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol (2013) 1.29

Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease. Eur J Nucl Med Mol Imaging (2012) 1.25

The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction. JAMA Neurol (2013) 1.25

Dynamic single photon emission computed tomography--basic principles and cardiac applications. Phys Med Biol (2010) 1.24

Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. Neuroimage Clin (2013) 1.21

Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol (2013) 1.19

Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. Neuroimage (2013) 1.17

Age and amyloid-related alterations in default network habituation to stimulus repetition. Neurobiol Aging (2011) 1.16

Spatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data. Neuroimage (2013) 1.11

Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia. Neurology (2013) 1.11

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review. Alzheimers Res Ther (2013) 1.09

Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers. Neurology (2011) 1.09

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain (2015) 1.09

The neuropsychology of normal aging and preclinical Alzheimer's disease. Alzheimers Dement (2013) 1.09

Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype. Biol Psychiatry (2012) 1.07

Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications. Alzheimers Res Ther (2011) 1.07

Effects of age and β-amyloid on cognitive changes in normal elderly people. Neurobiol Aging (2012) 1.06

Asymptomatic Alzheimer's disease: a prodrome or a state of resilience? Curr Alzheimer Res (2011) 1.05

Ushering in the study and treatment of preclinical Alzheimer disease. Nat Rev Neurol (2013) 1.03

Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study. J Affect Disord (2011) 1.02

Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study. J Neuropathol Exp Neurol (2011) 0.99

The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimers Dement (2013) 0.98

Brain imaging in the study of Alzheimer's disease. Neuroimage (2011) 0.97

Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Adv Pharmacol (2012) 0.94

Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Med (2010) 0.93

Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease. Neurobiol Aging (2013) 0.93

Neural correlates of the interactive relationship between memory deficits and depressive symptoms in nondemented elderly: resting fMRI study. Behav Brain Res (2011) 0.92

Disclosure of amyloid imaging results to research participants: has the time come? Alzheimers Dement (2013) 0.91

In vivo human amyloid imaging. Curr Alzheimer Res (2011) 0.90

Is amyloid-β harmful to the brain? Insights from human imaging studies. Brain (2015) 0.88

Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD. Neurology (2014) 0.88

Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage. J Cereb Blood Flow Metab (2014) 0.88

Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease. Ann Clin Transl Neurol (2015) 0.88

Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography. Am J Geriatr Psychiatry (2013) 0.87

Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease. Alzheimers Dement (2014) 0.87

Spatial navigation-a unique window into physiological and pathological aging. Front Aging Neurosci (2012) 0.86

Should we disclose amyloid imaging results to cognitively normal individuals? Neurodegener Dis Manag (2013) 0.86

The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations. Neuropsychol Rev (2014) 0.86

Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease. Neurosci Biobehav Rev (2014) 0.86

Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review. Neurodegener Dis Manag (2012) 0.85

Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's disease. J Int Neuropsychol Soc (2014) 0.85

JointMMCC: joint maximum-margin classification and clustering of imaging data. IEEE Trans Med Imaging (2012) 0.84

Memory decline shows stronger associations with estimated spatial patterns of amyloid deposition progression than total amyloid burden. Neurobiol Aging (2013) 0.84

Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age. Cogn Behav Neurol (2015) 0.83

Cortical florbetapir-PET amyloid load in prodromal Alzheimer's disease patients. EJNMMI Res (2013) 0.83

Functional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adults. PLoS One (2013) 0.82

Comparison of qualitative and quantitative imaging characteristics of [(11)C]PiB and [(18)F]flutemetamol in normal control and Alzheimer's subjects. Neuroimage Clin (2015) 0.82

Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? Cereb Cortex (2013) 0.81

Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers. Neuroimage Clin (2013) 0.81

Rethinking on the concept of biomarkers in preclinical Alzheimer's disease. Neurol Sci (2016) 0.80

Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study. J Int Neuropsychol Soc (2015) 0.80

Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort. Alzheimers Dement (2015) 0.80

Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough. Imaging Med (2012) 0.79

Nonlinear longitudinal trajectories of cholesterol and neuropsychological function. Neuropsychology (2013) 0.79

Brain structure and function as mediators of the effects of amyloid on memory. Neurology (2015) 0.79

Biomarkers for the Early Detection and Progression of Alzheimer's Disease. Neurotherapeutics (2016) 0.78

Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition. J Int Neuropsychol Soc (2015) 0.78

Vascular risk and FDDNP-PET influence cognitive performance. J Alzheimers Dis (2013) 0.77

Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging. Front Neurol (2016) 0.77

Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study. Alzheimers Dement (2016) 0.76

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population. PLoS One (2015) 0.76

Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status. Clin Neuropsychol (2016) 0.75

Voxelwise Relationships Between Distribution Volume Ratio and Cerebral Blood Flow: Implications for Analysis of β-Amyloid Images. J Nucl Med (2015) 0.75

Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis. Alzheimers Dement (Amst) (2016) 0.75

Discrepancies between fluid and crystallized ability in healthy adults: a behavioral marker of preclinical Alzheimer's disease. Neurobiol Aging (2016) 0.75

Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline. J Alzheimers Dis (2015) 0.75

Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults. Front Aging Neurosci (2017) 0.75

Recruiting to preclinical Alzheimer's disease clinical trials through registries. Alzheimers Dement (N Y) (2017) 0.75

Association between serotonin denervation and resting-state functional connectivity in mild cognitive impairment. Hum Brain Mapp (2017) 0.75

The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry (1968) 18.69

[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain (2008) 9.64

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology (1992) 9.30

Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95

Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci (2003) 7.26

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain (2007) 6.39

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab (2005) 6.25

One-year age changes in MRI brain volumes in older adults. Cereb Cortex (2000) 5.16

PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging (2007) 4.47

Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (2000) 3.89

Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann Neurol (2006) 2.68

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia (2008) 2.58

Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model. Neuroimage (2003) 2.09

Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging (1995) 1.90

Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. Neuroimage (2007) 1.67

A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol (1994) 30.72

Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med (1995) 20.53

An STS-based map of the human genome. Science (1995) 17.72

Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci (2000) 15.54

[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10

Calcium-channel blockade and incidence of cancer in aged populations. Lancet (1996) 8.04

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84

Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70

Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature (2000) 7.46

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med (1999) 6.92

The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90

The ClpXP and ClpAP proteases degrade proteins with carboxy-terminal peptide tails added by the SsrA-tagging system. Genes Dev (1998) 6.73

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet (1998) 5.85

Energetic optimization of ion conduction rate by the K+ selectivity filter. Nature (2001) 5.45

One-year age changes in MRI brain volumes in older adults. Cereb Cortex (2000) 5.16

A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes. Cell (2001) 4.36

Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst (1998) 4.27

Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16

Depressive symptoms and physical decline in community-dwelling older persons. JAMA (1998) 4.05

Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci (2001) 4.01

Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature (2007) 3.69

U(L)31 and U(L)34 proteins of herpes simplex virus type 1 form a complex that accumulates at the nuclear rim and is required for envelopment of nucleocapsids. J Virol (2001) 3.56

Regulation of human placental development by oxygen tension. Science (1997) 3.49

Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci (2000) 3.45

Exploring the effect of depression on physical disability: longitudinal evidence from the established populations for epidemiologic studies of the elderly. Am J Public Health (1999) 3.17

Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol (2000) 3.13

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol (1993) 3.12

Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09

Herpes simplex virus type 1 U(L)34 gene product is required for viral envelopment. J Virol (2000) 3.06

Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology (2009) 2.84

Coronectomy vs. total removal for third molar extraction: a systematic review. J Dent Res (2012) 2.84

Waterborne outbreak of rotavirus diarrhoea in adults in China caused by a novel rotavirus. Lancet (1984) 2.82

Two different lateral amygdala cell populations contribute to the initiation and storage of memory. Nat Neurosci (2001) 2.82

Lower extremity performance in nondisabled older persons as a predictor of subsequent hospitalization. J Gerontol A Biol Sci Med Sci (2000) 2.81

Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nat Cell Biol (2000) 2.81

Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer (2008) 2.79

Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys (1994) 2.77

Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology (1998) 2.70

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry (2001) 2.70

Ecological genomics of marine Roseobacters. Appl Environ Microbiol (2007) 2.68

Adhesion formation after previous caesarean section-a meta-analysis and systematic review. BJOG (2010) 2.66

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2007) 2.65

Expression of the plant cyclin-dependent kinase inhibitor ICK1 affects cell division, plant growth and morphology. Plant J (2000) 2.59

Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol (1995) 2.54

Brevetoxin concentrations in marine aerosol: human exposure levels during a Karenia brevis harmful algal bloom. Bull Environ Contam Toxicol (2003) 2.53

Complete genome sequence of the genetically tractable hydrogenotrophic methanogen Methanococcus maripaludis. J Bacteriol (2004) 2.47

Silicatein filaments and subunits from a marine sponge direct the polymerization of silica and silicones in vitro. Proc Natl Acad Sci U S A (1999) 2.47

Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci U S A (2001) 2.44

The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci (1998) 2.40

Rotation of subunits during catalysis by Escherichia coli F1-ATPase. Proc Natl Acad Sci U S A (1995) 2.39

Dynamics of bubble oscillation in constrained media and mechanisms of vessel rupture in SWL. Ultrasound Med Biol (2001) 2.37

Hand-grip strength predicts incident disability in non-disabled older men. Age Ageing (1999) 2.34

LAI inversion algorithm based on directional reflectance kernels. J Environ Manage (2006) 2.31

Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology (2001) 2.30

A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data. Pharmacogenomics J (2010) 2.30

Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation (2001) 2.29

Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol (2000) 2.29

DnaK, DnaJ, and GrpE are required for flagellum synthesis in Escherichia coli. J Bacteriol (1992) 2.28

Is self-rated health comparable across cultures and genders? J Gerontol B Psychol Sci Soc Sci (1998) 2.28

Risk factors for falling in home-dwelling older women with stroke: the Women's Health and Aging Study. Stroke (2003) 2.28

Survival time comparison between Hawley and clear overlay retainers: a randomized trial. J Dent Res (2011) 2.26

Integrin switching regulates normal trophoblast invasion. Development (1994) 2.23

Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun (1997) 2.19

Detection of the Plasmodium falciparum antigen histidine-rich protein 2 in blood of pregnant women: implications for diagnosing placental malaria. J Clin Microbiol (1999) 2.16

An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry (2010) 2.14

Parental underestimates of adolescent risk behavior: a randomized, controlled trial of a parental monitoring intervention. J Adolesc Health (2000) 2.12

UNC-5, a transmembrane protein with immunoglobulin and thrombospondin type 1 domains, guides cell and pioneer axon migrations in C. elegans. Cell (1992) 2.12

Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging (Milano) (2000) 2.09

Genetic determination of Colles' fracture and differential bone mass in women with and without Colles' fracture. J Bone Miner Res (2000) 2.07

Major salivary gland imaging. Radiology (2000) 2.07

A comparison of delays in the treatment of cancer with radiation in Canada and the United States. Int J Radiat Oncol Biol Phys (1995) 2.02

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science (1986) 2.00

Concomitant sensitivity to orientation, direction, and color of cells in layers 2, 3, and 4 of monkey striate cortex. J Neurosci (1995) 1.97

Meta-analysis of genome-wide association studies for personality. Mol Psychiatry (2010) 1.96

STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci U S A (1999) 1.96

The segment polarity gene hedgehog is required for progression of the morphogenetic furrow in the developing Drosophila eye. Cell (1993) 1.96

Foot pain and disability in older persons: an epidemiologic survey. J Am Geriatr Soc (1995) 1.95

Face masks to prevent transmission of influenza virus: a systematic review. Epidemiol Infect (2010) 1.92

Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain. Curr Pharm Des (2004) 1.90

Does a centralized radiotherapy system provide adequate access to care? J Clin Oncol (1997) 1.90

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.89

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci (2001) 1.88

Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med (1997) 1.85

Aging successfully until death in old age: opportunities for increasing active life expectancy. Am J Epidemiol (1999) 1.83

X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J Histochem Cytochem (2000) 1.81

The protective effect of emotional vitality on adverse health outcomes in disabled older women. J Am Geriatr Soc (2000) 1.80

Executive function, memory, and gait speed decline in well-functioning older adults. J Gerontol A Biol Sci Med Sci (2010) 1.80

Termination and slippage by bacteriophage T7 RNA polymerase. J Mol Biol (1993) 1.80

Measuring muscular strength of the lower limbs by hand-held dynamometer: a standard protocol. Aging (Milano) (1999) 1.79

Sexual behaviour and contraceptive use among unmarried, young women migrant workers in five cities in China. Reprod Health Matters (2001) 1.77